Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older.
about
Outcomes and quality of life following breast cancer treatment in older women: when, why, how much, and what do women want?Early-Stage Breast Cancer in the Elderly: Confronting an Old Clinical ProblemExercise Prevention of Cardiovascular Disease in Breast Cancer SurvivorsTaxanes in the elderly patient with metastatic breast cancerComprehensive geriatric assessment for older women with early breast cancer - a systematic review of literatureAdjuvant Systemic Therapy in Older Breast Cancer Women: Can We Optimize the Level of Care?Specific Aspects of Breast Cancer Therapy of Elderly WomenObesity, insulin resistance and cancer riskDiabetes mellitus and prognosis in women with breast cancer: A systematic review and meta-analysisRelation of comorbidities and patient navigation with the time to diagnostic resolution after abnormal cancer screening.Surveillance Mammography in Older Patients With Breast Cancer-Can We Ever Stop?: A Review.An observational study of the prevalence and incidence of comorbid conditions in older women with breast cancerNo Survival Benefit for Patients with Treatment in Certified Breast Centers-A Population-based Evaluation of German Cancer Registry Data.The association of mood disorders with breast cancer survival: an investigation of linked cancer registration and hospital admission data for South East EnglandEvaluation of three algorithms to identify incident breast cancer in Medicare claims data.The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort studyCancer outcomes in low-income elders: is there an advantage to being on Medicaid?Association between oestrogens receptor expressions in breast cancer and comorbidities: a cross-sectional, population-based study.Memory and cancer: a review of the literatureSurveillance mammography for Medicaid/Medicare breast cancer patientsEffect of radiotherapy after breast-conserving surgery in older patients with early breast cancer and breast ductal carcinoma in situ: a meta-analysis.The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survivalSurvival of patients with lung cancer and diabetes mellitus.Long-Term Cause-Specific Mortality After Surgery for Women With Breast Cancer: A 20-Year Follow-Up Study From Surveillance, Epidemiology, and End Results Cancer Registries.Squamous cell carcinoma of the tongue in a female with advanced breast cancer: A case report of an elderly patient presenting with two types of cancer.Quality of life in a prospective cohort of elderly women with and without cancer.Cardiovascular Late Effects and Exercise Treatment in Breast Cancer: Current Evidence and Future DirectionsBreast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study.Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901.Medical comorbidities predict mortality in women with a history of early stage breast cancer.Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians.Unstaged cancer in the United States: a population-based study.Impact of hyperglycemia on survival and infection-related adverse events in patients with metastatic colorectal cancer who were receiving palliative chemotherapy.Older breast cancer survivors' symptom beliefs.Predictors and outcomes of surgeons' referral of older breast cancer patients to medical oncologistsImpact of acquired comorbidities on all-cause mortality rates among older breast cancer survivorsPre-exercise participation cardiovascular screening in a heterogeneous cohort of adult cancer patients.Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (alliance)Older women, breast cancer, and social support.Factors affecting receipt of chemotherapy in women with breast cancer.
P2860
Q24804538-FDC6F5AB-EBA2-4E8C-9C62-B9ED745DC821Q26782584-0A14B08D-6FBD-4021-9599-518D50CF21E8Q26785410-47860ADB-55DD-4395-A5E6-9424079C334FQ26785458-5BF4885B-F0C3-4BB9-B9C8-4F2831CA419CQ27002642-C1D4A95D-580F-414C-9703-6B6671CB35EFQ27025860-102DEEBE-83C7-4E0C-B9A2-5E81DD408204Q28079170-BA3496FF-DB4F-47AF-B8FB-6F3FD40500ECQ28189539-7C083B8E-B54D-49E4-B5CE-007DE8781F58Q30240165-B4B56AC1-2DC9-4793-AF21-6F31C3741A54Q30275886-B5F3FC14-FA20-4C38-B17C-99C62140B59AQ30395721-02A1AEA2-A034-4DF6-8E8A-E409C334BFACQ30519487-7B880F7B-6151-4490-B3B3-2FF6B91367AAQ30977803-3A226B4C-B680-4F4F-87D1-9BDD5E5C5663Q31029367-722CD4F0-0630-4AEA-AD99-56F86C97E6EDQ31127274-7444CEBB-65D2-4420-91E1-22DE4F5BA295Q33432354-DA6F2CB0-7A81-4353-AABC-0F62CCBAB51FQ33551498-5B336D4D-BE53-4D55-84E7-E40F91810FCCQ33645985-B78109F5-437A-43EF-9B6C-ADB54F1C3C37Q33663544-3AD45DE3-2548-4C37-9DDD-250FE50861E2Q33674887-26C09438-8FAF-45EC-8AC0-689888AEB275Q33709640-A1DF7DD9-8F02-4177-87F6-1D81C776D4F3Q33716455-778F2024-72A5-4F6C-A40D-670DFCDB5CDFQ33748272-E5646A24-1978-4914-8D64-A005B7136BAEQ33764936-877D3B92-B43A-4072-B146-E64F63D4E9D1Q33778427-9D0BDC93-92D3-4444-AEDC-7836135321C5Q33871574-9491747E-663A-4951-9B9D-219B2EF17D21Q33907581-04B7336E-22AA-489E-AE9C-7D7970331BE6Q33915023-D8E78982-AF9E-4561-B3D4-C52276D3E6A4Q33927985-C8D1D1EE-811E-4FDC-9BF9-C8CCE56528B8Q33956785-B7CB0A85-0D41-48A5-87C5-8861D38B01C3Q33990818-BFE8190F-BE28-4173-BBB8-F6086DD1638CQ34026882-DE52FEFC-4B57-41DF-9CA2-8F85B03CE5A0Q34043430-AB7F5A35-61C9-4803-A053-8638B2AE915BQ34052283-5AF4CB81-E5AE-470A-9965-3B9291F4DCD4Q34099121-ECFF8E62-1FDB-498C-B1B9-05FC5791F440Q34104905-C784B34B-8E1C-4E0A-8199-D1472B545F55Q34127943-804FA149-D284-4174-90E2-06286F8A3C9BQ34168190-9619378B-CB39-488D-B27C-A568FE96F4ABQ34222488-FE46327B-098F-4735-BFBF-E9AF38767F8BQ34272100-896E7B39-4700-4C52-B6B1-1354B00A96D0
P2860
Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Effect of age and comorbidity ...... ients aged 55 years and older.
@ast
Effect of age and comorbidity ...... ients aged 55 years and older.
@en
Effect of age and comorbidity ...... ients aged 55 years and older.
@nl
type
label
Effect of age and comorbidity ...... ients aged 55 years and older.
@ast
Effect of age and comorbidity ...... ients aged 55 years and older.
@en
Effect of age and comorbidity ...... ients aged 55 years and older.
@nl
prefLabel
Effect of age and comorbidity ...... ients aged 55 years and older.
@ast
Effect of age and comorbidity ...... ients aged 55 years and older.
@en
Effect of age and comorbidity ...... ients aged 55 years and older.
@nl
P2093
P356
P1476
Effect of age and comorbidity ...... ients aged 55 years and older.
@en
P2093
P304
P356
10.1001/JAMA.285.7.885
P407
P577
2001-02-01T00:00:00Z